Grants and Contributions:
Title:
Ex vivo use of mouse tumor microdissections for preclinical development of cancer immunotherapies
Agreement Number:
979207
Agreement Value:
$99,500.00
Agreement Date:
Sep 15, 2021 - Nov 30, 2022
Description:
The project aims to establish the utility of the technology to test, in a single ex vivo experiment, several combinations of immunotherapies to identify the most effective one, and to screen murine tumor models to identify the best preclinical model to study a given immunotherapy.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H2R 2P2
Reference Number:
172-2021-2022-Q3-979207
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
773986138
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 75 days.
Amendment Date
Aug 30, 2022
Recipient's Operating Name:
MisoChip
Recipient's Legal Name:
9397-2677 Québec inc.
Federal Riding Name:
Papineau
Federal Riding Number:
24055
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: